L3VLUP
ProSign in

DNLI · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

DNLIAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • DNLI
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterDNLIAMGN
Q3 20204 holders, $406m16 holders, $16.3bn
Q4 20207 holders, $1.6bn19 holders, $14.0bn
Q1 20217 holders, $1.2bn16 holders, $14.5bn
Q2 20215 holders, $1.7bn23 holders, $13.8bn
Q3 20216 holders, $1.1bn24 holders, $11.6bn
Q4 20214 holders, $709m21 holders, $10.4bn
Q1 20223 holders, $507m23 holders, $9.9bn
Q2 20225 holders, $481m28 holders, $9.7bn
Q3 20228 holders, $629m21 holders, $7.9bn
Q4 20226 holders, $766m24 holders, $9.3bn
Q1 20234 holders, $423m22 holders, $8.4bn
Q2 20236 holders, $760m26 holders, $7.4bn
Q3 20235 holders, $539m26 holders, $8.7bn
Q4 20238 holders, $577m24 holders, $8.4bn
Q1 20249 holders, $669m25 holders, $6.7bn
Q2 20249 holders, $829m20 holders, $8.0bn
Q3 20247 holders, $1.1bn21 holders, $8.8bn
Q4 20246 holders, $625m20 holders, $8.2bn
Q1 20255 holders, $422m25 holders, $12.0bn
Q2 20254 holders, $270m20 holders, $10.2bn
Q3 20255 holders, $333m17 holders, $10.4bn
Q4 20256 holders, $342m19 holders, $18.0bn
Q1 20267 holders, $372m15 holders, $21.4bn
Q2 20265 holders, $514m23 holders, $24.9bn
DNLI

Denali Therapeutics Inc

Holders
9
Reported value
$829m
Buyers
5
Sellers
3

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
20
Reported value
$8.0bn
Buyers
11
Sellers
9

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q2 2024

Among the 25 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only DNLI (5)

Artisan Partners LP, Baillie Gifford & Co, PDT Partners LLC, Point72 Asset Management LP, Wellington Management Group LLP

Only AMGN (16)

AllianceBernstein LP, ARK Investment Management LLC, Bridgewater Associates LP, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Farallon Capital Management LLC, Fidelity (FMR LLC), Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Neuberger Berman Group LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →